share_log

公告精选 | 融创中国前5月合同销售跌超四成;亚洲水泥(中国)获控股股东私有化

Selected Announcements | Sunac's contract sales in the first five months of the year fell by more than 40%; Asia Cement(China) acquired by a controlling shareholder.

cls.cn ·  Jun 6 07:46

How did Seazen's rental income perform with a drop of over 40% in contract sales for the first five months? What is the premium rate for Asia Cement (China) to receive a privatization offer from its controlling shareholders?

Important announcements for Hong Kong stocks yesterday and this morning: 1) Company News

1) Company News

$TRULY INT'L (00732.HK)$The unaudited comprehensive operating net income for the first five months of the year was approximately HKD 7.268 billion, a year-on-year increase of about 19.5%.

$SEAZEN (01030.HK)$The cumulative contracted sales for the first five months were RMB 19.754 billion, a year-on-year decrease of 44.67%; the cumulative rental income was RMB 4.798 billion, and the commercial operation income was RMB 5.143 billion.

$SUNAC (01918.HK)$The cumulative contracted sales for the first five months were RMB 24.72 billion, a year-on-year decrease of 45.21%.

$COUNTRY GARDEN (02007.HK)$Contracted sales in May were RMB 4.29 billion, a year-on-year decrease of 76%.

$TIMES CHINA (01233.HK)$The cumulative contracted sales for the first five months were RMB 3.586 billion, a year-on-year decrease of 57.12%.

$GREENTOWN CHINA (03900.HK)$Total contracted sales for the first five months were approximately RMB 98.8 billion, a year-on-year decrease of 9.02%.

$ALPHAMAB-B (09966.HK)$Reached cooperation with ArriVent on the research, development and commercialization of ADC products.

According to the cooperation agreement, CStone Pharmaceuticals has the right to receive one-time, non-refundable prepayments and potential milestone payments, including product registration, development and sales milestone payments, totaling up to US$616 million. In addition, CStone Pharmaceuticals also has the right to charge ArriVent licensing fees for the use of various ADC products.

$SINO BIOPHARM (01177.HK)$The positive phase I clinical data of FS222 "CD137/PD-L1" shows strong anti-tumor activity and controllable safety.

$GOLDSTREAM INV (01328.HK)$Intends to carry out strategic cooperation with SenseTime Group in AI+Finance, AI-based ecological enterprises, and other areas.

$YUEXIU PROPERTY (00123.HK)$Enter into a forex forward contract with Yuexiu Enterprises to purchase USD 350 million with CNY.

$CHINA VANKE (02202.HK)$The funds will be deposited into the designated account of the agent bank to fully pay the USD 600 million medium-term notes due on June 7.

2) Privatization and repurchase dynamics

$ASIA CEMENT CH (00743.HK)$The controlling shareholder proposes privatization and plans to exchange each planned share for cash of HKD 3.22, a discount of about 3.01% compared to the closing price on May 28, 2024.

According to the announcement, after the plan takes effect, the offeror will directly hold 100% of the company's shares, and the listing status of the shares on the Hong Kong Stock Exchange will be cancelled.

$TENCENT (00700.HK)$Repurchase 2.62 million shares for approximately HKD 1.002 billion, with a repurchase price of HKD 377.6-387.8 per share.

$JF WEALTH (09636.HK)$Repurchase 973,000 shares for HKD 11.9588 million, with a repurchase price of HKD 11.9-12.46 per share.

$HSBC HOLDINGS (00005.HK)$Repurchase 3.3544 million shares for HKD 231 million, with a repurchase price of HKD 68.7-69.4 per share.

Editor/tolk

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment